Use of xanthine derivatives for reducing the pathological...

Details Use of xanthine derivatives for reducing the pathological... Use of xanthine derivatives for reducing the pathological...

C - Chemistry, Metallurgy

07

D

C07D 473/06 (2006.01) A61K 31/52 (2006.01) A61K 31/522 (2006.01) C07D 473/04 (2006.01)

Patent

CA 2187081

Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and process for their preparation. Tertiary 1-(hydroxyalkyl)-4-alkylxanthines are suitable for the production of pharmaceuticals for the treatment of disorders which is associated with a pathologically increased reactivity of eosinophilic granulocytes. Novel xanthine derivatives and process for their preparation are described.

Les 1-(hydroxyalkyle)-4-alkylxanthines tertiaires conviennent à la préparation de médicaments pour le traitement de maladies liées à la réactivité pathologiquement accrue des granulocytes éosinophiles. L'invention porte sur de nouveaux dérivés de xanthine et sur leur procédé de production.

Affiliated with

Also associated with

Rating

Use of xanthine derivatives for reducing the pathological... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of xanthine derivatives for reducing the pathological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xanthine derivatives for reducing the pathological... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1846077